On the 27th, the official website of the State Administration of Traditional Chinese Medicine issued the "Announcement on Further Regulating the Use and Production of "Qingfei Paidu Decoction"."
The "Announcement" pointed out that recently, Shijiazhuang City, Hebei Province and Jilin Province successively issued the "Shijiazhuang City New Coronavirus Pneumonia Traditional Chinese Medicine Prevention Program" and the "Jilin Province New Coronary Pneumonia Traditional Chinese Medicine Prevention Program", focusing on giving full play to Chinese medicine in epidemic prevention and control and clinical practice. The unique role in the treatment, the "Qingfei Paidu Decoction" is used as the first choice for the intervention of closely isolated personnel and the treatment of patients with new coronary pneumonia.
But at the same time, the State Administration of Traditional Chinese Medicine has recently learned that some Chinese medicine companies use single-flavor Chinese medicine formula granules to prepare "Qingfei Paidu Decoction" for clinical use.
The "Announcement" stated that in order to ensure the efficacy of "Qingfei Paidu Decoction", the State Administration of Traditional Chinese Medicine issued a "Special Instructions on Regulating the Use and Production of "Qingfei Paidu Decoction" on May 12, 2020, emphasizing "' "Qingfei Paidu Decoction" should be prepared with traditional Chinese medicine decoctions and used in water decoction. The raw gypsum must be decocted first, and the co-decoction and co-cooking procedure is essential.
For this reason, the State Administration of Traditional Chinese Medicine once again emphasized in the "Announcement":
First, in order to ensure the safety and effectiveness of clinical medication, the "Qingfei Paidu Decoction" should be prepared with traditional Chinese medicine pieces, and used in water decoction. The gypsum must be decocted first, and the co-decoction and co-cooking procedure is essential.
Do not use single-flavored Chinese medicine formula granules to mix and use, so as not to reduce the efficacy and delay the treatment.
Second, "Qingfei Paidu Decoction" has fully studied and judged the core pathogenesis of new coronary pneumonia, has exquisite compatibility, and has the characteristics and advantages of universality, quick effect and decisive victory.
The first course of treatment must be used as the original prescription, and the second course of treatment can be added or subtracted based on the actual situation.
To ensure the purity of the medicine, it is not recommended to use it with other medicines (including proprietary Chinese medicines).
Third, Chinese medicine companies should earnestly perform their main responsibilities, strictly implement the "Drug Administration Law" and other relevant laws and regulations, and conduct drug production in accordance with laws and regulations.
For Chinese medicine companies that produce "Qingfei Paidu Decoction" compound granules without the approval of the State Drug Administration, they will bear corresponding legal liabilities in accordance with the law.
(Li Bin, CCTV reporter)